08:00 , Feb 13, 2012 |  BC Week In Review  |  Company News

Bio-ID Diagnostics Inc., Trovagene deal

TrovaGene completed its acquisition of Bio-ID's MultiGen Diagnostics Inc. subsidiary for 750,000 shares valued at $562,500 based on TrovaGene's close of $0.75 on Feb. 7, the day before the deal closed (see BioCentury, Jan. 16)....
08:00 , Jan 16, 2012 |  BC Week In Review  |  Company News

Bio-ID Diagnostics Inc., Trovagene deal

TrovaGene will acquire MultiGen Diagnostics Inc., a subsidiary of Bio-ID based in San Diego, Calif., for 750,000 shares valued at $412,500 based on TrovaGene's close of $0.55 on Jan. 5, the day before the deal...
07:00 , Mar 22, 2010 |  BC Week In Review  |  Company News

Enzo, Bio-ID Diagnostics sales and marketing update

Bio-ID’s MultiGEN Diagnostics Inc. subsidiary granted Enzo Biochem's Clinical Lab division exclusive rights to market MultiGEN's diagnostic tests based on multiplex DNA sequencing in New York and non-exclusive rights elsewhere in the U.S. Enzo Biochem...